Allworth Financial LP lifted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 7.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,006 shares of the biotechnology company’s stock after buying an additional 67 shares during the quarter. Allworth Financial LP’s holdings in Axon Enterprise were worth $402,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of AXON. Motley Fool Asset Management LLC grew its holdings in shares of Axon Enterprise by 238.7% during the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock worth $153,981,000 after buying an additional 346,838 shares in the last quarter. 1832 Asset Management L.P. purchased a new stake in Axon Enterprise in the first quarter valued at approximately $81,630,000. International Assets Investment Management LLC purchased a new stake in Axon Enterprise in the third quarter valued at approximately $871,860,000. Vanguard Group Inc. grew its holdings in Axon Enterprise by 2.7% in the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock valued at $2,547,878,000 after purchasing an additional 212,401 shares during the period. Finally, Swedbank AB purchased a new stake in Axon Enterprise in the first quarter valued at approximately $39,923,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
AXON has been the subject of a number of recent analyst reports. Barclays boosted their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Needham & Company LLC boosted their target price on shares of Axon Enterprise from $400.00 to $525.00 and gave the company a “buy” rating in a report on Tuesday, October 22nd. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. JMP Securities boosted their price objective on shares of Axon Enterprise from $375.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. Finally, Bank of America began coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $380.00 price objective for the company. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $382.85.
Axon Enterprise Trading Down 0.2 %
NASDAQ AXON opened at $444.00 on Wednesday. The company’s fifty day simple moving average is $398.94 and its 200-day simple moving average is $338.43. Axon Enterprise, Inc. has a 52 week low of $199.50 and a 52 week high of $455.17. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. The stock has a market cap of $33.51 billion, a P/E ratio of 129.82, a PEG ratio of 11.91 and a beta of 0.94.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The business had revenue of $504.00 million for the quarter, compared to analysts’ expectations of $478.35 million. During the same period in the previous year, the company posted $0.80 earnings per share. The business’s revenue for the quarter was up 34.5% compared to the same quarter last year. Equities research analysts predict that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.
Insider Activity at Axon Enterprise
In related news, CEO Patrick W. Smith sold 80,300 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the sale, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CEO Patrick W. Smith sold 80,300 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the sale, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Matthew R. Mcbrady sold 2,000 shares of the company’s stock in a transaction on Friday, August 9th. The shares were sold at an average price of $364.66, for a total transaction of $729,320.00. Following the completion of the sale, the director now directly owns 4,892 shares in the company, valued at $1,783,916.72. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 371,172 shares of company stock valued at $137,000,162 over the last ninety days. Corporate insiders own 6.10% of the company’s stock.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
- Five stocks we like better than Axon Enterprise
- How to Calculate Return on Investment (ROI)
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- Insider Trading – What You Need to Know
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- What Are Dividend Achievers? An Introduction
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.